We are pleased to announce that Daniela Kenzelmann Broz, SFL Director Medical Affairs and Julien Gaudias, SFL Director Regulatory Affairs will present a free webinar entitled “Orphan Drug Designation Application in the EU” (30 January 2020, 4 to 5 pm CET).

The webinar, moderated by Anja Bührer, SFL Head Regulatory Affairs, will provide an overview of key aspects regarding the application for Orphan Drug Designation in the EU – relevant to any company developing orphan drugs.

Register now to take advantage of the expert insights provided by the SFL team on this highly relevant topic and find out the most important considerations for preparing an Orphan Drug Application in the EU.

SFL provides strategic and operational support for both medical affairs and regulatory projects, including pre- and post-authorization activities.